We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

FDA Approves Novartis Kisqali for Combination Breast Cancer Therapy

News   Mar 21, 2017 | Original story from Novartis

 
FDA Approves Novartis Kisqali for Combination Breast Cancer Therapy
 
 
Advertisement
 

RELATED ARTICLES

Biomarker That Appears Before Stomach Cancer Develops May Aid Early Detection

News

A promising new biomarker that appears in patients before stomach cancer develops may help with early detection of the disease and improve patient response to therapy, according to findings in a study led by University of Arizona Health Sciences researchers.

READ MORE

Cholesterol-Lowering Drugs Linked to Reduced Cancer-Related Deaths in Women

News

Women with breast cancer, colorectal cancer, or melanoma, who were taking cholesterol-lowering medications, were less likely to die from cancer, according to a new study published in the British Journal of Clinical Pharmacology.

READ MORE

UK Researchers Set To Explore Human Challenge Studies for COVID-19 Vaccine Development

News

Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE